Qin Lv

664 total citations
19 papers, 519 citations indexed

About

Qin Lv is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qin Lv has authored 19 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qin Lv's work include Advanced biosensing and bioanalysis techniques (3 papers), Systemic Sclerosis and Related Diseases (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Qin Lv is often cited by papers focused on Advanced biosensing and bioanalysis techniques (3 papers), Systemic Sclerosis and Related Diseases (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Qin Lv collaborates with scholars based in China and Germany. Qin Lv's co-authors include Hailin Wang, Qiang Zhao, Shan Chen, Xianfang Meng, Jing Xiong, Fang-Fang He, Pan Gao, Hua Su, Jianshe Liu and Kai Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Chemistry.

In The Last Decade

Qin Lv

18 papers receiving 510 citations

Peers

Countries citing papers authored by Qin Lv

Since Specialization

Citations

This map shows the geographic impact of Qin Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qin Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qin Lv more than expected).

Fields of papers citing papers by Qin Lv

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qin Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qin Lv. The network helps show where Qin Lv may publish in the future.

Co-authorship network of co-authors of Qin Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Qin Lv. A scholar is included among the top collaborators of Qin Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qin Lv. Qin Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	A machine learning-based risk warning platform for potentially inappropriate prescriptions for elderly patients with cardiovascular disease 2022 ·Frontiers in Pharmacology ·Xingwei Wu, (unknown), (unknown), Qin Lv, (unknown), (unknown), (unknown), (unknown)	8
2	Wenyang Huazhuo Tongluo formula alleviates pulmonary vascular injury and downregulates HIF-1α in bleomycin-induced systemic sclerosis mouse model 2022 ·BMC Complementary Medicine and Therapies ·Kai Li, Qian Wang, Qin Lv, (unknown), Li Han, (unknown), (unknown), (unknown)	2
3	The Efficacy and Safety of Brolucizumab for the Treatment of nAMD: A Systematic Review and Meta-Analysis 2022 ·Frontiers in Pharmacology ·Junlan Chuan, (unknown), Yu-Mei Feng, Mengdan Wang, Gang Li, Qin Lv	2
4	Th17 cell‐derived miR‐155‐5p modulates interleukin‐17 and suppressor of cytokines signaling 1 expression during the progression of systemic sclerosis 2022 ·Journal of Clinical Laboratory Analysis ·Li Han, Qin Lv, (unknown), Linyun Li, Hong Zhang, (unknown)	8
5	Prediction and verification of the key ingredients and molecular targets of Guizhi Fuling capsule against tumour metastasis and resistance 2022 ·Li Han, Qin Lv, (unknown), (unknown), Ruijuan Du, (unknown), (unknown), (unknown)	1
6	Safe and Effective Treatment for Anemic Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis on Roxadustat 2021 ·Frontiers in Pharmacology ·Mei Tang, Changyu Zhu, Ting Yan, (unknown), Qin Lv, Junlan Chuan	17
7	First aggregation-induced emission-active probe for species-specific detection of β-galactosidase 2021 ·Talanta ·Gao Tang, Huiling Li, Ya Wu, Cheng Deng, Yuji Xie, Jing Wang, Yali Yang, Qin Lv, Qiaofeng Jin, Yihan Chen, (unknown), Yi Zhong, Xueke Li, Qianqian Zhao, Li Zhang, Mingxing Xie	18
8	Systematic review and meta-analysis of the efficacy of N-acetylcysteine in the treatment of acute exacerbation of chronic obstructive pulmonary disease 2021 ·Annals of Palliative Medicine ·(unknown), Jun Zou, Qin Lv, Yan Yang	9
9	The complete chloroplast genome sequence of Cinnamomum septentrionale (Lauraceae) from Sichuan Province, China, a medicinal plant and phylogenetic analysis 2021 ·SHILAP Revista de lepidopterología ·Qin Lv, (unknown), Xiaojuan Guo	0
10	Association between Working Hours and Anxiety/Depression of Medical Staff during Large-Scale Epidemic Outbreak of COVID-19: A Cross-Sectional Study 2020 ·Psychiatry Investigation ·(unknown), Xiaojing Liu, Ying He, Qin Lv, Sibo Xu	5
11	Effectiveness of Cefoperazone-sulbactam alone and Combined with Tigecycline in the Treatment of Multi-drug Resistant Acinetobacter Baumannii Pulmonary Infection 2020 ·Journal of College of Physicians And Surgeons Pakistan ·Qin Lv, Yan-Ling Deng, Xiaobo Zhu, Jia Ruan, Lin Chen	7
12	The Release of Norepinephrine in C57BL/6J Mice Treated with 6-Hydroxydopamine (6-OHDA) is Associated with Translocations in Enteric Escherichia coli via the QseC Histidine Kinase Receptor 2020 ·Medical Science Monitor ·(unknown), Huamei Chen, Qin Lv, (unknown), Kun Yang	2
13	A novel tumor suppressor SPINK5 targets Wnt/β‐catenin signaling pathway in esophageal cancer 2019 ·Cancer Medicine ·Qian Wang, Qin Lv, (unknown), Lei Yang, (unknown), (unknown), (unknown), (unknown)	29
14	[Effects of Wenyang Huazhuo Tongluo Recipe Containing Serum on Transforming Growth Factor β1/ Smad Signaling Pathway of Skin Fibroblasts in Systemic Sclerosis]. 2015 ·PubMed ·(unknown), Qin Lv, Xianzhang Huang, (unknown), Lei Yang, (unknown)	3
15	Aptamer fluorescence anisotropy sensors for adenosine triphosphate by comprehensive screening tetramethylrhodamine labeled nucleotides 2015 ·Biosensors and Bioelectronics ·Qiang Zhao, Qin Lv, Hailin Wang	33
16	High Serum Uric Acid and Increased Risk of Type 2 Diabetes: A Systemic Review and Meta-Analysis of Prospective Cohort Studies 2013 ·PLoS ONE ·Qin Lv, Xianfang Meng, Fang-Fang He, Shan Chen, Hua Su, Jing Xiong, Pan Gao, Xiujuan Tian, Jianshe Liu, Zhonghua Zhu, Kai Huang, Chun Zhang	277
17	Identification of Allosteric Nucleotide Sites of Tetramethylrhodamine-Labeled Aptamer for Noncompetitive Aptamer-Based Fluorescence Anisotropy Detection of a Small Molecule, Ochratoxin A 2013 ·Analytical Chemistry ·Qiang Zhao, Qin Lv, Hailin Wang	83
18	Dynamic Metabolic Profiling of Urine From Type 2 Diabetic KK-Ay Mice Treated with Repaglinide by GC-MS 2012 ·Analytical Letters ·(unknown), Lunzhao Yi, (unknown), Qin Lv, (unknown), Zhimin Zhang, Yi‐Zeng Liang, Jun He	7
19	Chromatographic fingerprint of Semen Armeniacae Amarae based on high-performance liquid chromatogram and chemometric methods 2011 ·Analytical Methods ·Qin Lv, Lunzhao Yi, (unknown), Yi‐Zeng Liang	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact